Investec initiates coverage on KIMS with ₹1,000 buy target
Krishna Institute of Medical Sciences (KIMS) gained after Investec initiated coverage with a “buy” rating and a target price of ₹1,000 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.